166 related articles for article (PubMed ID: 28939099)
61. Lymph node micrometastases is a poor prognostic factor for patients in pN0 gastric cancer: a meta-analysis of observational studies.
Li Y; Du P; Zhou Y; Cheng Q; Chen D; Wang D; Sun T; Zhou J; Patel R
J Surg Res; 2014 Oct; 191(2):413-22. PubMed ID: 25060322
[TBL] [Abstract][Full Text] [Related]
62. Clinicopathological and prognostic significance of aberrant Arpin expression in gastric cancer.
Li T; Zheng HM; Deng NM; Jiang YJ; Wang J; Zhang DL
World J Gastroenterol; 2017 Feb; 23(8):1450-1457. PubMed ID: 28293092
[TBL] [Abstract][Full Text] [Related]
63. Prognostic value of matrix metalloproteinase-9 in gastric cancer: a meta-analysis.
Chen J; Chen LJ; Zhou HC; Yang RB; Lu Y; Xia YL; Wu W; Hu LW
Hepatogastroenterology; 2014; 61(130):518-24. PubMed ID: 24901174
[TBL] [Abstract][Full Text] [Related]
64. Association between the expression of T-cadherin and vascular endothelial growth factor and the prognosis of patients with gastric cancer.
Wei B; Shi H; Lu X; Shi A; Cheng Y; Dong L
Mol Med Rep; 2015 Aug; 12(2):2075-81. PubMed ID: 25847144
[TBL] [Abstract][Full Text] [Related]
65. [Study on the correlation between the expressions of nm23H1 mRNA, VEGF-C mRNA and lymphatic metastases, survival rate with gastric cancer].
Ding GF; Li JC; Li CS; Xu YF; Sun Y; Chen XR
Fen Zi Xi Bao Sheng Wu Xue Bao; 2006 Feb; 39(1):46-54. PubMed ID: 16944571
[TBL] [Abstract][Full Text] [Related]
66. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
[TBL] [Abstract][Full Text] [Related]
67. [Expression of vascular endothelial growth factor receptor 3 in human breast cancer and its significance].
Wu J; Chen L; Zhou W; Liu X; Chen X; Miao D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Dec; 27(12):1487-91. PubMed ID: 24640372
[TBL] [Abstract][Full Text] [Related]
68. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
69. The effects of VEGF and VEGFR-2 on survival in patients with gastric cancer.
Ozdemir F; Akdogan R; Aydin F; Reis A; Kavgaci H; Gul S; Akdogan E
J Exp Clin Cancer Res; 2006 Mar; 25(1):83-8. PubMed ID: 16761623
[TBL] [Abstract][Full Text] [Related]
70. The clinical significance of snail protein expression in gastric cancer: a meta-analysis.
Chen X; Li J; Hu L; Yang W; Lu L; Jin H; Wei Z; Yang JY; Arabnia HR; Liu JS; Yang MQ; Deng Y
Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):22. PubMed ID: 27461247
[TBL] [Abstract][Full Text] [Related]
71. Prognostic value of NM23 in patients with gastric cancer: A systematic review and meta-analysis.
Wang QH; Han W; Chen MB; Bao J; Wang BF
J Cancer Res Ther; 2018 Sep; 14(Supplement):S556-S564. PubMed ID: 30249868
[TBL] [Abstract][Full Text] [Related]
72. SOX2 contributes to invasion and poor prognosis of gastric cancer: A meta-analysis.
Tang K; Liu J; Liu B; Meng C; Liao J
Medicine (Baltimore); 2022 Sep; 101(36):e30559. PubMed ID: 36086709
[TBL] [Abstract][Full Text] [Related]
73. Prognostic and clinicopathological significance of MLKL expression in cancer patients: a meta-analysis.
Hu B; Shi D; Lv X; Chen S; Huang Q; Xie M; Shao Z
BMC Cancer; 2018 Jul; 18(1):736. PubMed ID: 30005626
[TBL] [Abstract][Full Text] [Related]
74. HIF1A protein expression is correlated with clinical features in gastric cancer: an updated systematic review and meta-analysis.
Nam S; Lee Y
Sci Rep; 2024 Jun; 14(1):13736. PubMed ID: 38877062
[TBL] [Abstract][Full Text] [Related]
75. The Prognostic Value of Nanog Overexpression in Lung Cancer: A Meta-Analysis.
Cheng W; Wang H; Yuan J; Cheng Z; Xing D; Zhang M
Biomed Res Int; 2018; 2018():3429261. PubMed ID: 30627549
[TBL] [Abstract][Full Text] [Related]
76. Pathological and Prognostic Impacts of FGFR2 Overexpression in Gastric Cancer: A Meta-Analysis.
Kim HS; Kim JH; Jang HJ; Han B; Zang DY
J Cancer; 2019; 10(1):20-27. PubMed ID: 30662521
[TBL] [Abstract][Full Text] [Related]
77. Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysis.
Long B; Yu Z; Zhou H; Ma Z; Ren Y; Zhan H; Li L; Cao H; Jiao Z
Int J Surg; 2018 Aug; 56():242-249. PubMed ID: 29940258
[TBL] [Abstract][Full Text] [Related]
78. CD44 and CD44v6 are Correlated with Gastric Cancer Progression and Poor Patient Prognosis: Evidence from 42 Studies.
Fang M; Wu J; Lai X; Ai H; Tao Y; Zhu B; Huang L
Cell Physiol Biochem; 2016; 40(3-4):567-578. PubMed ID: 27889771
[TBL] [Abstract][Full Text] [Related]
79. Clinicopathologic Significance and Prognostic Value of B7 Homolog 1 in Gastric Cancer: A Systematic Review and Meta-Analysis.
Xu F; Feng G; Zhao H; Liu F; Xu L; Wang Q; An G
Medicine (Baltimore); 2015 Oct; 94(43):e1911. PubMed ID: 26512615
[TBL] [Abstract][Full Text] [Related]
80. Meta-analysis: E-cadherin immunoexpression as a potential prognosis biomarker related to gastric cancer metastasis in Asian patients.
Li T; Chen J; Liu QL; Huo ZH; Wang ZW
Eur Rev Med Pharmacol Sci; 2014; 18(18):2693-703. PubMed ID: 25317805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
